AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MUMBAI, Nov 1 Asia Pulse - Natco Pharma Ltd (BSE:524816) said it has received approval from the US Food and Drug Administration for its facility manufacturing finished dosage formulations at Kothur in Andhra Pradesh.
The Kothur unit will concentrate on manufacturing finished dosages exclusively for US and European markets and has already received approval from UK MHRA, the company informed the Bombay Stock Exchange Monday.
The unit spread over 20 acres has been equipped with simple mixers or tablet making machines, soft gel capsule machines, pellet making facilities, capsule filling (powder) machines, an independent R&D lab and a dedicated module for aerosols, it said.
Natco has taken up the expansion of its finished dosage manufacturing facility at Kothur ...